Jove
Visualize
Contact Us

Related Experiment Videos

[Vaccines against HIV].

Carol Holm-Hansen1

  • 1Nasjonalt folkehelseinstitutt, Divisjon for smittevern Postboks 4404 Nydalen 0403 Oslo. carol.holm-hansen@fhi.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|December 13, 2006
PubMed
Summary

Developing an effective HIV vaccine is crucial for controlling the pandemic, especially in resource-limited regions. Despite challenges like viral genetic diversity, new strategies offer optimism for a broadly protective vaccine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum: Enhancing Data Quality and Remote Accessibility in Clinical Trials: A SeroSelectTB Case Study in Ethiopia, Tanzania, and South Africa.

Applied clinical informatics·2026
Same author

Enhancing Data Quality and Remote Accessibility in Clinical Trials: A SeroSelectTB Case Study in Ethiopia, Tanzania, and South Africa.

Applied clinical informatics·2026
Same author

Lineage-Specific Proteomic Signatures in the <i>Mycobacterium tuberculosis</i> Complex Reveal Differential Abundance of Proteins Involved in Virulence, DNA Repair, CRISPR-Cas, Bioenergetics and Lipid Metabolism.

Frontiers in microbiology·2020
Same author

Vitamin D Deficiency is Associated with Increased Use of Antimicrobials among Preschool Girls in Ethiopia.

Nutrients·2019
Same author

Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex.

Scientific reports·2019
Same author

N<sub>ε</sub>- and O-Acetylation in Mycobacterium tuberculosis Lineage 7 and Lineage 4 Strains: Proteins Involved in Bioenergetics, Virulence, and Antimicrobial Resistance Are Acetylated.

Journal of proteome research·2017
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Context:

  • Vaccination is a primary method for controlling viral infections.
  • The HIV/AIDS pandemic remains a significant global health challenge, particularly in developing nations.
  • Limited access to antiretroviral therapy in some regions underscores the need for an effective HIV vaccine.

Purpose:

  • To explore the challenges and prospects of developing an effective human immunodeficiency virus (HIV) vaccine.
  • To highlight advancements in vaccine technology and delivery systems relevant to HIV vaccine development.
  • To assess the potential for a single vaccine effective against multiple HIV subtypes.

Summary:

  • Traditional vaccination strategies are effective for many viral diseases, but HIV presents unique challenges due to its high genetic variability.
  • Technological advancements are enabling novel vaccine designs and delivery methods.
  • Recent research suggests the possibility of creating a single vaccine capable of targeting diverse HIV subtypes, offering a promising avenue for future development.
  • Despite significant scientific hurdles and resource limitations, numerous candidate HIV vaccines are progressing through clinical trials.

Impact:

  • An effective HIV vaccine would revolutionize HIV/AIDS prevention and control efforts globally.
  • Successful vaccine development could significantly reduce the burden of HIV infection, especially in vulnerable populations.
  • Continued research and clinical trials are essential to overcoming the remaining challenges and achieving the goal of an accessible HIV vaccine.

Related Experiment Videos